Cancer

Title
A Phase III Trial Comparing the Effectiveness of Three Treatment Methods for Prostate Cancer in Individuals who have a Rising PSA after having a Radical Prostatectomy
Trial Number
203420042011
Number of Participants
1,764
Principal Investigator
Eligibility

Patients must be 18 years of age or older and have adenocarcinoma of the prostate treated primarily with radical prostatectomy, pathologically proven to be lymph node negative or lymph node status pathologically unknown. The post-radical prostatectomy entry PSA must be > or = to 1.0 and

Purpose

The purpose of this study is to compare the effects of three treatment methods for men with prostate cancer who have a rising PSA after prostatectomy surgery. The three methods are: radiation to the prostate bed only, hormone therapy for four to six months plus radiation therapy to the prostate bed, or hormone therapy for four to six months plus radiation therapy to the prostate bed and to the pelvic lymph nodes.

Enrollment

(708) 216-2568

MORE CLINICAL TRIALS

Clinical Trials

For more information call (888) LUHS-888.